Expanding mobile mammography fleet delivers increased imaging access

Charlotte Radiology is expanding its successful fleet of mobile imaging centers to meet increased demand and provide women with access to early detection cancer screenings at their place of employment, according to a company press release.

The fleet, which consists of a group of 38-foot-long buses outfitted with state-of-the-art breast screening facilities, has serviced more than 40,000 patients in 15 states since being deployed in 2011.

The addition of a fourth mobile mammography unit comes with an upgrade—the capability to perform onsite digital breast tomosynthesis, also known as 3D mammography, for a $55 out-of-pocket fee.

“The mobile breast centers bring early breast cancer detection right to the workplace,” said the company’s corporate health and community relations manager. Katie Yarborough, “allowing health-conscious employers the opportunity to provide their employees with a more convenient option for breast cancer screening.”

Read more about the mobile imaging fleet here.

 

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.